Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Nektar Therapeutics

NASDAQ: NKTR · Life Sciences · 5 alerts · CIK 906709

Share price
$36.44Close, Nov 16
Market cap
$1.25B
Shares outstanding
34.21MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Nektar Therapeutics filings on SEC EDGAR ↗

7:00 AM ET 8-K
Court & Legal Update

Nektar Therapeutics Court & Legal Update

A jury in the U.S. District Court for the Northern District of California awarded Nektar Therapeutics $90 million in damages plus interest in its lawsuit against Eli Lilly. The jury found that Lilly breached the implied covenant of good faith and fair dealing regarding the license agreement for rezpegaldesleukin. The verdict remains subject to post-trial proceedings and potential appeals.

Counterparty
Eli Lilly and Company

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.